All Stories

  1. Cardiovascular and Renal Outcomes of Incretin-based Therapies: A Review of Recent Clinical Trials

    Article • Current Cardiology Reviews, January 2021, Bentham Science Publishers

    Dr Georgios Kyriakos, Spyridon Savvanis, Eleni Memi

  2. SGLT2 Inhibitors and Cardiovascular Outcomes: Do They Differ or There is a Class Effect? New Insights from the EMPA-REG OUTCOME trial and the CVD-REAL Study

    Article • Current Cardiology Reviews, January 2021, Bentham Science Publishers

    Spyridon Savvanis, Dr Georgios Kyriakos, Eleni Memi

  3. PCSK9 inhibitors and cardiovascular disease: impact on cardiovascular outcomes

    Article • Current Drug Discovery Technologies, December 2018, Bentham Science Publishers

    Christos Damaskos, Spyridon Savvanis

  4. Nutritional Aspects of Bone Health and Fracture Healing

    Article • Journal of Osteoporosis, January 2017, Hindawi Publishing Corporation

    Spyridon Savvanis